Betty Liu
Allergy & Immunology · Long Beach, CANPI 1033301247
Payments from drug & device makers
Across 190 payments — averaging $25.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$759
- CSL Behring$632
- Amgen$578
- Sanofi$452
- GSK$395
- Regeneron Healthcare Solutions, Inc.$388
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,79098%
- Education$1012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 28 | $759 |
| CSL Behring | 28 | $632 |
| Amgen(2 entities) | 19 | $578 |
| Sanofi | 14 | $452 |
| GSK | 18 | $395 |
| Regeneron Healthcare Solutions, Inc. | 10 | $388 |
| Genentech USA, Inc. | 11 | $243 |
| Optinose US, Inc. | 9 | $241 |
| Pfizer | 8 | $149 |
| Aurinia Pharma U.S., Inc. | 1 | $121 |
| Boehringer Ingelheim | 6 | $115 |
| Grifols USA, LLC | 4 | $106 |
| Novartis | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| Teva Pharmaceuticals USA, Inc. | 5 | $90 |
| Bio Products Laboratory USA, Inc. | 4 | $60 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $49 |
| Pharming Healthcare, Inc. | 2 | $48 |
| Shire North American Group Inc | 2 | $43 |
| Incyte Corporation | 2 | $42 |
| Alk-abello, Inc | 2 | $38 |
| LEO Pharma Inc. | 1 | $32 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| Merck | 1 | $25 |
| Pulmonx Corporation | 1 | $20 |
| Cycle Pharmaceuticals Inc | 1 | $16 |
| Kaleo, Inc. | 1 | $15 |
| Octapharma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,891 in reported general payments places this provider in the 60th percentile of 426 allergy & immunology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lagevrio (Eua)Molnupiravir | 11 | $5,712 |
| Epinephrine | 15 | $2,205 |
| Azelastine Hcl | 34 | $530 |
| Ipratropium Bromide | 16 | $331 |
| Montelukast Sodium | 60 | $327 |
| Fluticasone Propionate | 25 | $307 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckLagevrio (Eua) | $25 | $5,71211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 426 allergy & immunology providers in California.
Other allergy & immunology in Long Beach
- Kenneth KimLong Beach$18.5M
- Steven MeltzerLong Beach$1.3M
- Purvi MehraSan Diego$6.3M
- Bob GengSan Diego$6M
- Alexander GreinerSan Diego$4.8M
- Tonny TanusBakersfield$4.5M
- Raffi TachdjianSanta Monica$4.2M
- Vinay MehtaLaguna Niguel$3.3M
- Alan GoldsobelSan Jose$3.3M
- Steven WeinsteinHuntington Beach$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.